Boehringer Ingelheim faces fines up to $931,000

German drug-maker Boehringer Ingelheim GmbH was fined nearly $1 million for withholding files relating to the conditions of the blood thinner, Pradaxa.

On Monday, December 9, District Judge David Herndon ruled that Boehringer executives acted “in bad faith” by not making Pradaxa’s development and marketing documents accessible to physicians and consumers.

Judge Herndon is handling over 1,700 consolidated lawsuits alleging that Pradaxa use resulted in severe and, sometimes, fatal bleeding. Boehringer is set to make an appearance in federal court in August of 2014. Before the federal trial, Boehringer is scheduled for trial in Delaware, Connecticut, California, and Illinois state courts.

Defective pharmaceuticals can jeopardize victims’ health and financial stability. If you have been harmed by your prescription medicine, you could be entitled to compensation. Contact Ritter & Associates for legal consultations in San Diego. Call (619) 296-0123 today to speak with an experienced attorney.